receptor tyrosine protein kinase erbb 3 market

Global Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-04-17
  • Report ID: 96607
  • Pages: 109
  • Format: prudent report format

Snapshot

The global Receptor Tyrosine Protein Kinase ERBB 3 market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Receptor Tyrosine Protein Kinase ERBB 3 by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
Table of Contents
1 Industry Overview
1.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry
Figure Receptor Tyrosine Protein Kinase ERBB 3 Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Receptor Tyrosine Protein Kinase ERBB 3
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Receptor Tyrosine Protein Kinase ERBB 3
1.2.2 Downstream
Table Application Segment of Receptor Tyrosine Protein Kinase ERBB 3
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Receptor Tyrosine Protein Kinase ERBB 3 Market by Type
3.1 By Type
3.1.1 BA-0702
Table Major Company List of BA-0702
3.1.2 CDX-3379
Table Major Company List of CDX-3379
3.1.3 Elgemtumab
Table Major Company List of Elgemtumab
3.1.4 ETBX-031
Table Major Company List of ETBX-031
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market 2016-2020, by Type, in USD Million
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market Growth 2016-2020, by Type, in USD Million
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market 2016-2020, by Type, in Volume
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast 2021-2026, by Type, in USD Million
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 AstraZeneca Plc (Company Profile, Sales Data etc.)
4.1.1 AstraZeneca Plc Profile
Table AstraZeneca Plc Overview List
4.1.2 AstraZeneca Plc Products & Services
4.1.3 AstraZeneca Plc Business Operation Conditions
Table Business Operation of AstraZeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 AVEO Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.2.1 AVEO Pharmaceuticals, Inc. Profile
Table AVEO Pharmaceuticals, Inc. Overview List
4.2.2 AVEO Pharmaceuticals, Inc. Products & Services
4.2.3 AVEO Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of AVEO Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Etubics Corporation (Company Profile, Sales Data etc.)
4.3.1 Etubics Corporation Profile
Table Etubics Corporation Overview List
4.3.2 Etubics Corporation Products & Services
4.3.3 Etubics Corporation Business Operation Conditions
Table Business Operation of Etubics Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
4.4.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
4.4.2 F. Hoffmann-La Roche Ltd. Products & Services
4.4.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 GamaMabs Pharma S.A. (Company Profile, Sales Data etc.)
4.5.1 GamaMabs Pharma S.A. Profile
Table GamaMabs Pharma S.A. Overview List
4.5.2 GamaMabs Pharma S.A. Products & Services
4.5.3 GamaMabs Pharma S.A. Business Operation Conditions
Table Business Operation of GamaMabs Pharma S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.6.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
4.6.2 GlaxoSmithKline Plc Products & Services
4.6.3 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Hanmi Pharmaceuticals, Co. Ltd. (Company Profile, Sales Data etc.)
4.7.1 Hanmi Pharmaceuticals, Co. Ltd. Profile
Table Hanmi Pharmaceuticals, Co. Ltd. Overview List
4.7.2 Hanmi Pharmaceuticals, Co. Ltd. Products & Services
4.7.3 Hanmi Pharmaceuticals, Co. Ltd. Business Operation Conditions
Table Business Operation of Hanmi Pharmaceuticals, Co. Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 ImmunoGen, Inc. (Company Profile, Sales Data etc.)
4.8.1 ImmunoGen, Inc. Profile
Table ImmunoGen, Inc. Overview List
4.8.2 ImmunoGen, Inc. Products & Services
4.8.3 ImmunoGen, Inc. Business Operation Conditions
Table Business Operation of ImmunoGen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Kolltan Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.9.1 Kolltan Pharmaceuticals, Inc. Profile
Table Kolltan Pharmaceuticals, Inc. Overview List
4.9.2 Kolltan Pharmaceuticals, Inc. Products & Services
4.9.3 Kolltan Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Kolltan Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Merrimack Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.10.1 Merrimack Pharmaceuticals, Inc. Profile
Table Merrimack Pharmaceuticals, Inc. Overview List
4.10.2 Merrimack Pharmaceuticals, Inc. Products & Services
4.10.3 Merrimack Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Merrimack Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Merus B.V. (Company Profile, Sales Data etc.)
4.11.1 Merus B.V. Profile
Table Merus B.V. Overview List
4.11.2 Merus B.V. Products & Services
4.11.3 Merus B.V. Business Operation Conditions
Table Business Operation of Merus B.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Novartis AG (Company Profile, Sales Data etc.)
4.12.1 Novartis AG Profile
Table Novartis AG Overview List
4.12.2 Novartis AG Products & Services
4.12.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Cost, Gross Margin)
4.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Company Profile, Sales Data etc.)
4.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Profile
Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Overview List
4.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Products & Services
4.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Business Operation Conditions
Table Business Operation of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Sihuan Pharmaceutical Holdings Group Ltd. (Company Profile, Sales Data etc.)
4.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Profile
Table Sihuan Pharmaceutical Holdings Group Ltd. Overview List
4.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Products & Services
4.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Business Operation Conditions
Table Business Operation of Sihuan Pharmaceutical Holdings Group Ltd. (Sales Revenue, Cost, Gross Margin)
4.15 Sorrento Therapeutics, Inc. (Company Profile, Sales Data etc.)
4.15.1 Sorrento Therapeutics, Inc. Profile
Table Sorrento Therapeutics, Inc. Overview List
4.15.2 Sorrento Therapeutics, Inc. Products & Services
4.15.3 Sorrento Therapeutics, Inc. Business Operation Conditions
Table Business Operation of Sorrento Therapeutics, Inc. (Sales Revenue, Cost, Gross Margin)
4.16 Symphogen A/S (Company Profile, Sales Data etc.)
4.16.1 Symphogen A/S Profile
Table Symphogen A/S Overview List
4.16.2 Symphogen A/S Products & Services
4.16.3 Symphogen A/S Business Operation Conditions
Table Business Operation of Symphogen A/S (Sales Revenue, Cost, Gross Margin)
4.17 Takis S.r.l. (Company Profile, Sales Data etc.)
4.17.1 Takis S.r.l. Profile
Table Takis S.r.l. Overview List
4.17.2 Takis S.r.l. Products & Services
4.17.3 Takis S.r.l. Business Operation Conditions
Table Business Operation of Takis S.r.l. (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue 2016-2020, by Company, in USD Million
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue Share in 2020, by Company, in USD Million
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Volume 2016-2020, by Company, in Volume
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Receptor Tyrosine Protein Kinase ERBB 3 Market Concentration, in 2020
Figure Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Market Concentration, in 2020
Figure Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 MMarket Concentration, in 2020
Figure South America Receptor Tyrosine Protein Kinase ERBB 3 Market Concentration, in 2020
Figure Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Non-Small Cell Carcinoma
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Non-Small Cell Carcinoma, 2016-2020, in USD Million
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Non-Small Cell Carcinoma, 2016-2020, in Volume
6.1.2 Demand in Solid Tumor
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Solid Tumor, 2016-2020, in USD Million
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Solid Tumor, 2016-2020, in Volume
6.1.3 Demand in Melanoma
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Melanoma, 2016-2020, in USD Million
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Melanoma, 2016-2020, in Volume
6.1.4 Demand in Colorectal Cancer
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Colorectal Cancer, 2016-2020, in USD Million
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Colorectal Cancer, 2016-2020, in Volume
6.1.5 Demand in Others
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Others, 2016-2020, in USD Million
Figure Receptor Tyrosine Protein Kinase ERBB 3 Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Receptor Tyrosine Protein Kinase ERBB 3 Demand Forecast 2021-2026, by Application, in USD Million
Figure Receptor Tyrosine Protein Kinase ERBB 3 Market Growth 2021-2026, by Application, in USD Million
Figure Receptor Tyrosine Protein Kinase ERBB 3 Market Share in 2026, by Application, in USD Million
Table Receptor Tyrosine Protein Kinase ERBB 3 Demand Forecast 2021-2026, by Application, in Volume
Table Receptor Tyrosine Protein Kinase ERBB 3 Market Growth 2021-2026, by Application, in Volume
Table Receptor Tyrosine Protein Kinase ERBB 3 Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Receptor Tyrosine Protein Kinase ERBB 3 Production 2016-2020, by Region, in USD Million
Table Receptor Tyrosine Protein Kinase ERBB 3 Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market 2016-2020, by Region, in USD Million
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share 2016-2020, by Region, in USD Million
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market 2016-2020, by Region, in Volume
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in USD Million
Figure North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in USD Million
Table North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in USD Million
Figure Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in USD Million
Table Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in USD Million
Figure South America Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in USD Million
Table South America Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast 2021-2026, by Region, in USD Million
Table Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.